Vanda Pharmaceuticals Inc (VNDA) — Cash Flow-to-Debt Ratio
Vanda Pharmaceuticals Inc (VNDA) has a Cash Flow-to-Debt Ratio of -0.18x as of December 2025, meaning its operating cash flow of $-29.42 Million could theoretically repay 0% of its total liabilities ($161.76 Million) in one year. Explore VNDA long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Vanda Pharmaceuticals Inc Cash Flow-to-Debt Ratio (2004–2025)
Historical debt coverage capacity for Vanda Pharmaceuticals Inc across 22 annual periods. Also explore Vanda Pharmaceuticals Inc total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Vanda Pharmaceuticals Inc (2004–2025)
Year-by-year debt coverage analysis for Vanda Pharmaceuticals Inc. For market capitalisation and broader financial context, see VNDA market cap.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.68x | $-109.44 Million | $161.76 Million | ▼ -405.2% |
| 2024 | -0.13x | $-15.76 Million | $117.66 Million | ▼ -208.3% |
| 2023 | 0.12x | $12.80 Million | $103.53 Million | ▼ -58.6% |
| 2022 | 0.30x | $31.98 Million | $107.05 Million | ▼ -58.7% |
| 2021 | 0.72x | $64.21 Million | $88.86 Million | ▲ +11.9% |
| 2020 | 0.65x | $51.77 Million | $80.19 Million | ▲ +2.3% |
| 2019 | 0.63x | $45.95 Million | $72.80 Million | ▲ +19.4% |
| 2018 | 0.53x | $29.99 Million | $56.71 Million | ▲ +2074.3% |
| 2017 | -0.03x | $-1.98 Million | $74.04 Million | ▲ +73.9% |
| 2016 | -0.10x | $-8.10 Million | $79.04 Million | ▼ -165.9% |
| 2015 | 0.16x | $12.45 Million | $80.02 Million | ▲ +102.1% |
| 2014 | -7.49x | $-81.55 Million | $10.89 Million | ▼ -1777.4% |
| 2013 | -0.40x | $-39.59 Million | $99.22 Million | ▼ -11.5% |
| 2012 | -0.36x | $-44.92 Million | $125.54 Million | ▼ -87.8% |
| 2011 | -0.19x | $-28.41 Million | $149.14 Million | ▼ -206.5% |
| 2010 | -0.06x | $-10.90 Million | $175.37 Million | ▼ -107.4% |
| 2009 | 0.84x | $169.34 Million | $202.68 Million | ▲ +107.1% |
| 2008 | -11.74x | $-45.96 Million | $3.91 Million | ▼ -198.6% |
| 2007 | -3.93x | $-51.64 Million | $13.13 Million | ▲ +27.6% |
| 2006 | -5.43x | $-51.62 Million | $9.50 Million | ▼ -56.0% |
| 2005 | -3.48x | $-17.71 Million | $5.09 Million | ▲ +26.9% |
| 2004 | -4.76x | $-8.61 Million | $1.81 Million | — |